Collegium Pharmaceutical, Inc.

DB:354 Stock Report

Market Cap: €925.8m

Collegium Pharmaceutical Future Growth

Future criteria checks 3/6

Collegium Pharmaceutical is forecast to grow earnings and revenue by 22% and 2.5% per annum respectively while EPS is expected to grow by 15.9% per annum.

Key information

22.0%

Earnings growth rate

15.9%

EPS growth rate

Pharmaceuticals earnings growth19.5%
Revenue growth rate2.5%
Future return on equityn/a
Analyst coverage

Low

Last updated11 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:354 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026760131N/A3145
12/31/20257401033563425
12/31/2024629712012565
9/30/202459989192194N/A
6/30/2024577100276277N/A
3/31/202456793308309N/A
12/31/202356748274275N/A
9/30/20235479266268N/A
6/30/2023537-11235236N/A
3/31/2023525-29176177N/A
12/31/2022464-25123124N/A
9/30/2022362-439394N/A
6/30/2022314-356769N/A
3/31/2022273435658N/A
12/31/202127772102104N/A
9/30/20213261048790N/A
6/30/2021326107102107N/A
3/31/202132142115121N/A
12/31/202031027-28094N/A
9/30/202030818-28687N/A
6/30/20203020-31359N/A
3/31/2020299-13-34130N/A
12/31/2019297-232128N/A
9/30/2019296-114754N/A
6/30/2019293-228190N/A
3/31/2019291-30123131N/A
12/31/2018280-39145169N/A
9/30/2018218-6691114N/A
6/30/2018160-62N/A59N/A
3/31/201890-70N/A-14N/A
12/31/201728-75N/A-67N/A
9/30/201719-85N/A-77N/A
6/30/20177-98N/A-84N/A
3/31/20174-102N/A-87N/A
12/31/20162-94N/A-75N/A
9/30/20160-76N/A-61N/A
6/30/2016N/A-59N/A-48N/A
3/31/2016N/A-40N/A-31N/A
12/31/2015N/A-20N/A-22N/A
9/30/2015N/A-15N/A-20N/A
6/30/2015N/A-13N/A-18N/A
3/31/2015N/A-12N/A-16N/A
12/31/2014N/A-21N/A-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 354's forecast earnings growth (22% per year) is above the savings rate (1%).

Earnings vs Market: 354's earnings (22% per year) are forecast to grow faster than the German market (20.7% per year).

High Growth Earnings: 354's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 354's revenue (2.5% per year) is forecast to grow slower than the German market (5.6% per year).

High Growth Revenue: 354's revenue (2.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 354's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y